How have ARGSQ shares performed in 2024?

Argos Therapeutics' stock was trading at $0.0540 on January 1st, 2024. Since then, ARGSQ stock has increased by 0.0% and is now trading at $0.0540. View the best growth stocks for 2024 here .

How were Argos Therapeutics' earnings last quarter?

Argos Therapeutics Inc (OTCMKTS:ARGSQ) issued its earnings results on Wednesday, August, 9th. The biopharmaceutical company reported ($4.20) EPS for the quarter, topping analysts' consensus estimates of ($4.50) by $0.30. The biopharmaceutical company earned $0.07 million during the quarter, compared to analysts' expectations of $0.10 million.

When did Argos Therapeutics' stock split?

Argos Therapeutics shares reverse split on Friday, January 19th 2018. The 1-20 reverse split was announced on Thursday, January 18th 2018. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, January 18th 2018. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.

How do I buy shares of Argos Therapeutics?

Shares of ARGSQ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

OTCMKTS:ARGSQ

Argos Therapeutics (ARGSQ) Stock Price, News & Analysis

→ SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad)

Free ARGSQ Stock Alerts

$0.05

0.00 (0.00%)

(As of 10/10/2019)

Compare

Today's Range: $0.05
▼
$0.05
50-Day Range: $0.05
▼
$0.05
52-Week Range: $0.02
▼
$0.25

Volume: N/A
Average Volume: 13,394 shs
Market Capitalization: $571,698.00

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Stock Analysis

Get Argos Therapeutics alerts:

Ad DTI

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

Click here for the full story

About Argos Therapeutics Stock (OTCMKTS:ARGSQ)

Argos Therapeutics, Inc., an immuno-oncology company, focuses on the development and commercialization of individualized immunotherapies for the treatment of cancer and infectious diseases in North America. The company develops immunotherapies based on its proprietary technology platform, Arcelis. Its product candidates include rocapuldencel-T, which is in Phase III clinical trial for the treatment of metastatic renal cell carcinoma. The company also develops AGS-004, which is in Phase II clinical trials for the treatment of human immunodeficiency virus. The company was formerly known as Merix Bioscience, Inc. and changed its name to Argos Therapeutics, Inc. in October 2004. Argos Therapeutics, Inc. was founded in 1997 and is based in Durham, North Carolina. On November 30, 2018, Argos Therapeutics, Inc. filed a voluntary petition for reorganization under Chapter 11 in the US Bankruptcy Court for the District of Delaware.

ARGSQ Stock Price History

30 days | 90 days | 365 days | Advanced Chart

ARGSQ Stock News Headlines

September 28, 2023 | investing.com

ARGSQ Historical Data

July 29, 2023 | mirror.co.uk

Seven Argos stores to shut NEXT month amid plans to close 100 for good by 2024

April 19, 2024 | DTI (Ad)

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

June 22, 2023 | mirror.co.uk

Argos launches massive half price garden furniture sale as the heatwave continues

April 9, 2023 | marketwatch.com

2023-2029 mRNA Vaccines & Therapeutics Market Opportunities and Forecast

April 6, 2023 | marketwatch.com

mRNA Vaccines & Therapeutics Market Share and Forecast till 2031

March 21, 2023 | mirror.co.uk

Argos, B&M, Iceland, Homesense and more all closing shops this month - see full list

February 25, 2023 | mirror.co.uk

Argos to close more shops for good in Sainsbury's plan – see which branches are affected

April 19, 2024 | DTI (Ad)

Biden’s $374B Giveaway Into This Sector

Biden’s Climate Bill Could Send Your Retirement Accounts Soaring – Or Diving See what this $374B giveaway could mean for your retirement right here

September 9, 2022 | dailymail.co.uk

Outrage as Argos sells G-strings for children

September 8, 2022 | dailymail.co.uk

Argos

See More Headlines

Receive ARGSQ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Argos Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 8/09/2017
Today: 4/19/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: Medical
Industry: Pharmaceutical Preparations
Sub-Industry: N/A
Current Symbol: OTCMKTS:ARGSQ
CUSIP: N/A
CIK: 1105533
Web: www.argostherapeutics.com
Phone: 919-287-6300
Fax: N/A
Employees: 21
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: N/A
Quick Ratio: N/A

Sales & Book Value

Annual Sales: $1.90 million
Price / Sales: 0.30
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: ($1.63) per share
Price / Book: -0.03

Miscellaneous

Outstanding Shares: 10,587,000
Free Float: N/A
Market Cap: $571,698.00
Optionable: Not Optionable
Beta: 2.47

7 Stocks to Own Before the 2024 Election

Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.

Get This Free Report

Key Executives

Dr. Charles A. Nicolette (Age 57)
Consultant
Mr. Jeffrey D. Abbey (Age 57)
Consultant & Director
Dr. Richard D. Katz (Age 55)
Consultant
Ms. Lori R. Harrelson CPA (Age 50)
CPA, VP of Fin.
Mr. William N. Wofford
Sec.

Key Competitors

View All Competitors

ARGSQ Stock Analysis - Frequently Asked Questions

How have ARGSQ shares performed in 2024?: Argos Therapeutics' stock was trading at $0.0540 on January 1st, 2024. Since then, ARGSQ stock has increased by 0.0% and is now trading at $0.0540.
View the best growth stocks for 2024 here.
How were Argos Therapeutics' earnings last quarter?: Argos Therapeutics Inc (OTCMKTS:ARGSQ) issued its earnings results on Wednesday, August, 9th. The biopharmaceutical company reported ($4.20) EPS for the quarter, topping analysts' consensus estimates of ($4.50) by $0.30. The biopharmaceutical company earned $0.07 million during the quarter, compared to analysts' expectations of $0.10 million.
When did Argos Therapeutics' stock split?: Argos Therapeutics shares reverse split on Friday, January 19th 2018. The 1-20 reverse split was announced on Thursday, January 18th 2018. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, January 18th 2018. An investor that had 100 shares of stock prior to the reverse split would have 5 shares after the split.
How do I buy shares of Argos Therapeutics?: Shares of ARGSQ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:ARGSQ) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Argos Therapeutics (ARGSQ) Stock Price, News & Analysis

About Argos Therapeutics Stock (OTCMKTS:ARGSQ)

ARGSQ Stock Price History

ARGSQ Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

ARGSQ Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info